Eric M. Kanza

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

Nicholas Opoku, Didier Bakajika, Eric M. Kanza et al. · The Lancet · 2018 · 300 citations · Full text

Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection

Didier Bakajika, Eric M. Kanza, Nicholas Opoku et al. · PLoS neglected tropical diseases · 2022 · 145 citations · Full text

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?

Klodeta Kura, Philip Milton, Jonathan I. D. Hamley et al. · Philosophical Transactions of the Royal Society B Biological Sciences · 2023 · 26 citations · Full text

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

Nicholas Opoku, Felix Doe, Bettina Dubben et al. · PLoS neglected tropical diseases · 2023 · 11 citations · Full text